Pharmacological treatment of anxiety disorders in children and adolescents: a review for practitioners.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Translational Pediatrics

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.21037/tp.2017.08.05PMID 29441280PMCID PMC5803020
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacologic Treatment of Pediatric Anxiety Disorders

  2016cited by this paper
• Pharmacotherapy for Pediatric Generalized Anxiety Disorder: A Systematic Evaluation of Efficacy, Safety and Tolerability

  2016cited by this paper
• Recent developments in the treatment of anxiety disorders in children and adolescents

  2016cited by this paper
• The Maudsley Prescribing Guidelines in Psychiatry

  2015cited by this paper
• EFFICACY AND TOLERABILITY OF ANTIDEPRESSANTS IN PEDIATRIC ANXIETY DISORDERS: A SYSTEMATIC REVIEW AND META‐ANALYSIS

  2015cited by this paper
• Pediatric and adolescent psychopharmacology

  2014cited by this paper
• Treatment of pediatric anxiety disorders

  2013cited by this paper
• Biological perspectives: hydroxyzine for anxiety: another look at an old drug.

  2013cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders

  2013cited by this paper
• Green's Child and Adolescent Clinical Psychopharmacology

  2013cited by this paper
• Efficacy and safety of antidepressant drug treatment in children and adolescents

  2012cited by this paper
• Psychopharmacologic treatment for pediatric anxiety disorders.

  2012cited by this paper
• Psychopharmacologic treatment of children and adolescents with anxiety disorders.

  2012cited by this paper
• Pharmacological Treatment of Anxiety Disorders in Children and Adolescents

  2012cited by this paper
• Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics.

  2011cited by this paper
• Assessment and Treatment of Anxiety Disorders in Children and Adolescents

  2011cited by this paper
• Assessment and Treatment of Anxiety Disorders in Children and Adolescents

  2011cited by this paper
• Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample.

  2011cited by this paper
• Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes.

  2010cited by this paper
• Child/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods

  2010cited by this paper
• Antidepressants I: Selective Serotonin Reuptake Inhibitors

  2010cited by this paper
• Suicidal Events in the Treatment for Adolescents With Depression Study (TADS)

  2010cited by this paper
• Pharmacotherapy for anxiety disorders in children and adolescents.

  2009cited by this paper
• Remission and recovery in the Treatment for Adolescents with Depression Study (TADS): acute and long-term outcomes.

  2009cited by this paper
• The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up.

  2009cited by this paper
• Clinical messages from the Treatment for Adolescents With Depression Study (TADS).

  2009cited by this paper
• Suicidal events in the Treatment for Adolescents With Depression Study (TADS).

  2009cited by this paper
• Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial.

  2008cited by this paper
• Anxiety disorders: a comprehensive review of pharmacotherapies.

  2008cited by this paper
• Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety.

  2008cited by this paper
• Prospective open-label pilot trial of mirtazapine in children and adolescents with social phobia.

  2008cited by this paper
• SSRI adverse events: How to monitor and manage

  2008cited by this paper
• The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.

  2007cited by this paper
• Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders.

  2007cited by this paper
• Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials.

  2007cited by this paper
• Treatment for Adolescents with Depression Study (TADS): safety results.

  2006cited by this paper
• Essential Psychopharmacology: The Prescriber’s Guide

  2006cited by this paper
• Psychopharmacology interventions for pediatric anxiety disorders: a research update.

  2006cited by this paper
• Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS).

  2006cited by this paper
• Selective serotonin reuptake inhibitors in pediatric psychopharmacology: a review of the evidence.

  2006cited by this paper
• Psychosocial and pharmacological treatment for pediatric anxiety disorders

  2006cited by this paper
• Selective serotonin reuptake inhibitor use in the treatment of the pediatric non-obsessive-compulsive disorder anxiety disorders.

  2006cited by this paper
• Review of Benzodiazepine use in Children and Adolescents

  2005cited by this paper
• Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

  2005cited by this paper
• Psychopharmacologic treatment of pediatric anxiety disorders.

  2005cited by this paper
• The Treatment for Adolescents With Depression Study (TADS): demographic and clinical characteristics.

  2005cited by this paper
• Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.

  2004cited by this paper
• Antidepressants for generalized anxiety disorder.

  2003cited by this paper
• Antidepressants for generalized anxiety disorder.

  2003cited by this paper
• Treating Children and Adolescents with Selective Serotonin Reuptake Inhibitors: How Long Is Appropriate?

  2002cited by this paper
• Fluvoxamine for the treatment of anxiety disorders in children and adolescents.

  2001cited by this paper
• Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group.

  2001cited by this paper
• Pharmacokinetics and Tolerability of Buspirone during Oral Administration to Children and Adolescents with Anxiety Disorder and Normal Healthy Adults

  2001cited by this paper
• Complications of SSRI Treatment

  2001cited by this paper
• Serotonergic agents in the treatment of social phobia in children and adolescents: A case series

  1999cited by this paper
• Antianxiety drugs.

  1994cited by this paper
• Anxiety disorders in children and adolescents: research, assessment and intervention (second edition)

  1993cited by this paper
• Child and Adolescent Psychiatry. A Comprehensive Textbook

  1992cited by this paper
• Anxiety disorders.

  1986cited by this paper
• The antidepressant drugs.

  1965cited by this paper

• Interventions for perinatal anxiety and related disorders in adolescents: A scoping review.

  2026cites this paper
• Feed, Read, and Grow: An Observational Study on the Impact of Educational Videos About Pediatric Anxiety

  2025cites this paper
• Prevalence and interventions for anxiety and depression in children and adolescents

  2025cites this paper
• Promoting mental health and preventing emotional disorders in vulnerable adolescent girls through VR-based extreme sports.

  2025cites this paper
• Traditional Chinese Medicine in the Management of Anxiety Disorders: A Narrative Review of Theoretical Foundations, Clinical Applications, and Modern Integrative Approaches

  2025cites this paper
• The risks versus the benefits of pharmacological intervention in social anxiety disorder in children

  2025cites this paper
• The impact of chronic fluoxetine treatment in adolescence or adulthood on context fear memory and perineuronal nets.

  2024cites this paper
• Childhood Anxiety Disorders.

  2024cites this paper
• Rehabilitation Intervention Is Associated With Improved Neurodevelopment and Modulation of Inflammatory Molecules in Children With Cerebral Palsy

  2024cites this paper
• Trends in the use and nonmedical use of sedatives-hypnotics in the population aged 12 to 64 years in Taiwan: a comparative analysis of the national surveys in 2014 and 2018

  2024cites this paper
• Investigating the Mediating Role of Social Dysfunction in the Relationship between Anxiety and Self-Harm in Children of Divorce: A Descriptive Study

  2024cites this paper
• Physiological correlates of anxiety in childhood and adolescence: A systematic review and meta-analysis.

  2024cites this paper
• Common pitfalls, and how to avoid them, in child and adolescent psychopharmacology: Part I

  2024cites this paper
• Risk factors of vitamin D deficiency in adolescent idiopathic scoliosis patients: A scoping review

  2024cites this paper
• The role of dorsal raphe nucleus serotonergic systems in emotional learning and memory in male BALB/c mice.

  2023cites this paper
• Impact of a publicly-funded pharmacare program policy on benzodiazepine dispensing among children and youth: a population-based natural experiment

  2023cites this paper
• Effect of stress-based interventions on the quality of life of people with an intellectual disability and their caregivers

  2023cites this paper
• Treatment of Learning Anxiety: A Bibliometric Review in Islamic Psychology

  2023cites this paper
• Efficacy of Cognitive Behavioral Therapy With Local Wisdom and Web-Based Counseling on Generalized Anxiety Disorders and Functional Gastrointestinal Disorders in Adolescent College Girls: Protocol for a Randomized Controlled Trial

  2023cites this paper
• Escitalopram and Sertraline Population Pharmacokinetic Analysis in Pediatric Patients

  2023cites this paper
• Psychopharmacological Strategies Employing Guanfacine in an Adolescent Girl with Postural Orthostatic Tachycardia Syndrome and Severe Posttraumatic Stress Disorder

  2022cites this paper
• The Management of Anxiety and Depression in Pediatrics

  2022cites this paper
• Anxiety Disorders in Children.

  2022cites this paper
• Evaluation of Cognitive-Behavioral Therapy Efficacy in the Treatment of Separation Anxiety Disorder in Childhood and Adolescence: a Systematic Review of Randomized Controlled Trials

  2021cites this paper
• When is it appropriate to treat children with social anxiety, pharmacologically?

  2021cites this paper
• Anxiety Disorders

  2021cites this paper
• Evaluation of Cognitive-Behavioral Therapy Efficacy in the Treatment of Separation Anxiety Disorder in Childhood and Adolescence: a Systematic Review of Randomized Controlled Trials

  2021cites this paper
• Secondary care specialist visits made by children and young people prescribed antidepressants in primary care: a descriptive study using the QResearch database

  2020cites this paper
• Pediatric Anxiety in Practice: A Knowledge and Needs Assessment of Pediatricians and Nurses.

  2020cites this paper
• Angststörungen und phobische Störungen

  2020cites this paper
• Mental Health Strategy and Policy

  2020cites this paper
• Caracterización química y evaluación de la actividad ansiolítica de Valeriana pilosa

  2020cites this paper
• Anxiety in Children

  2020cites this paper
• Therapeutic Potential of Exogenous Ketone Supplement Induced Ketosis in the Treatment of Psychiatric Disorders: Review of Current Literature

  2019cites this paper
• Internet-delivered treatment for young adults with anxiety and depression: Evaluation in routine clinical care and comparison with research trial outcomes.

  2019cites this paper
• Incidence of diagnosed pediatric anxiety disorders and use of prescription drugs: a nation-wide registry study

  2019cites this paper
• Anxiety related disorders in adolescents in the United Arab Emirates: a population based cross-sectional study

  2019cites this paper
• Impact of antidepressant Duloxetine on the lingual mucosa of male albino rats (An ultrastructural, and imunohistoc hemical study)

  2018cites this paper
• International Journal of Indigenous Herbs and Drugs

  year unknowncites this paper